| 0 |
ACRAL LENTIGINOUS MELANOMA STAGE III |
1 |
0.2000 |
| 1 |
PARANASAL SINUS BENIGN NEOPLASM |
2 |
0.2000 |
| 2 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE |
2 |
0.0870 |
| 3 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
55 |
0.0823 |
| 4 |
SWOLLEN JOINT COUNT |
16 |
0.0640 |
| 5 |
LUPUS VULGARIS |
75 |
0.0595 |
| 6 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
114 |
0.0569 |
| 7 |
BLEPHARAL PAPILLOMA |
1 |
0.0500 |
| 8 |
SWOLLEN JOINT COUNT INCREASED |
134 |
0.0420 |
| 9 |
DISLOCATION OF VERTEBRA |
85 |
0.0372 |
| 10 |
C-REACTIVE PROTEIN |
34 |
0.0367 |
| 11 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
76 |
0.0366 |
| 12 |
TENDER JOINT COUNT |
3 |
0.0357 |
| 13 |
RHEUMATOID FACTOR POSITIVE |
200 |
0.0346 |
| 14 |
RHEUMATIC FEVER |
152 |
0.0341 |
| 15 |
PRODUCT DIFFICULT TO REMOVE |
2 |
0.0333 |
| 16 |
SERONEGATIVE ARTHRITIS |
37 |
0.0323 |
| 17 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
230 |
0.0321 |
| 18 |
DUODENAL ULCER PERFORATION |
224 |
0.0301 |
| 19 |
FACET JOINT SYNDROME |
91 |
0.0279 |
| 20 |
RETINITIS |
48 |
0.0278 |
| 21 |
X-RAY ABNORMAL |
49 |
0.0274 |
| 22 |
PEMPHIGUS |
330 |
0.0264 |
| 23 |
OVARIAN ATROPHY |
2 |
0.0235 |
| 24 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
13 |
0.0232 |
| 25 |
IMPLANT SITE NECROSIS |
2 |
0.0227 |
| 26 |
HAND DEFORMITY |
294 |
0.0224 |
| 27 |
PERIPHERAL VENOUS DISEASE |
82 |
0.0201 |
| 28 |
HELICOBACTER INFECTION |
205 |
0.0199 |
| 29 |
BILIARY CANCER METASTATIC |
1 |
0.0192 |
| 30 |
GRIP STRENGTH |
4 |
0.0175 |
| 31 |
HYPOCHOLESTEROLAEMIA |
6 |
0.0170 |
| 32 |
PERICARDITIS |
278 |
0.0165 |
| 33 |
DRUG TOLERANCE DECREASED |
45 |
0.0160 |
| 34 |
BONE EROSION |
54 |
0.0153 |
| 35 |
APPLICATION SITE CELLULITIS |
1 |
0.0149 |
| 36 |
MUSCLE INJURY |
123 |
0.0148 |
| 37 |
ACQUIRED PORPHYRIA |
1 |
0.0141 |
| 38 |
SYNOVITIS |
251 |
0.0139 |
| 39 |
GLOSSODYNIA |
299 |
0.0133 |
| 40 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
86 |
0.0132 |
| 41 |
FOLLICULITIS |
138 |
0.0131 |
| 42 |
BREAST CANCER STAGE III |
82 |
0.0126 |
| 43 |
C-REACTIVE PROTEIN ABNORMAL |
73 |
0.0114 |
| 44 |
AUTOIMMUNE DISORDER |
108 |
0.0111 |
| 45 |
LIVE BIRTH |
91 |
0.0109 |
| 46 |
WOUND |
289 |
0.0103 |
| 47 |
LYMPH NODE CALCIFICATION |
2 |
0.0103 |
| 48 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
320 |
0.0090 |
| 49 |
PRODUCT PACKAGE ASSOCIATED INJURY |
20 |
0.0090 |
| 50 |
PRODUCT CLOSURE REMOVAL DIFFICULT |
9 |
0.0088 |
| 51 |
WOUND INFECTION |
96 |
0.0088 |
| 52 |
MECONIUM IN AMNIOTIC FLUID |
3 |
0.0085 |
| 53 |
HYPERCHOLESTEROLAEMIA |
82 |
0.0085 |
| 54 |
EXOSTOSIS |
77 |
0.0084 |
| 55 |
GRIP STRENGTH DECREASED |
74 |
0.0084 |
| 56 |
ANTI-THYROID ANTIBODY INCREASED |
1 |
0.0079 |
| 57 |
LIP DRY |
71 |
0.0078 |
| 58 |
WRONG PATIENT RECEIVED MEDICATION |
21 |
0.0077 |
| 59 |
SPONDYLITIS |
27 |
0.0074 |
| 60 |
OVERLAP SYNDROME |
5 |
0.0071 |
| 61 |
CONTRAINDICATED PRODUCT ADMINISTERED |
214 |
0.0071 |
| 62 |
BURSITIS |
85 |
0.0070 |
| 63 |
BLEPHAROSPASM |
44 |
0.0070 |
| 64 |
PORPHYRIA ACUTE |
10 |
0.0070 |
| 65 |
JOINT RANGE OF MOTION DECREASED |
92 |
0.0069 |
| 66 |
WALKING AID USER |
45 |
0.0068 |
| 67 |
INFUSION SITE REACTION |
20 |
0.0067 |
| 68 |
HYPNAGOGIC HALLUCINATION |
2 |
0.0066 |
| 69 |
PRESCRIBED OVERDOSE |
127 |
0.0066 |
| 70 |
ANAL DISCOMFORT |
1 |
0.0065 |
| 71 |
LIVER INJURY |
159 |
0.0065 |
| 72 |
FIBROMYALGIA |
152 |
0.0062 |
| 73 |
PULMONARY ARTERY DILATATION |
2 |
0.0058 |
| 74 |
JOINT DESTRUCTION |
9 |
0.0058 |
| 75 |
DEATH NEONATAL |
8 |
0.0057 |
| 76 |
ARTERIOVENOUS FISTULA OCCLUSION |
1 |
0.0057 |
| 77 |
BACTERIAL COLITIS |
1 |
0.0056 |
| 78 |
LOWER LIMB FRACTURE |
105 |
0.0055 |
| 79 |
IRRITABLE BOWEL SYNDROME |
117 |
0.0055 |
| 80 |
TYPE 2 DIABETES MELLITUS |
179 |
0.0053 |
| 81 |
HIP ARTHROPLASTY |
80 |
0.0052 |
| 82 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
57 |
0.0051 |
| 83 |
SCIATICA |
82 |
0.0051 |
| 84 |
BREAST CANCER STAGE II |
41 |
0.0049 |
| 85 |
ARTHROPATHY |
272 |
0.0049 |
| 86 |
LUPUS-LIKE SYNDROME |
44 |
0.0048 |
| 87 |
EYE INJURY |
14 |
0.0046 |
| 88 |
SINUS RHYTHM |
2 |
0.0046 |
| 89 |
PEAK EXPIRATORY FLOW RATE DECREASED |
2 |
0.0045 |
| 90 |
CERVICITIS |
2 |
0.0045 |
| 91 |
PRESCRIBED UNDERDOSE |
87 |
0.0044 |
| 92 |
DRUG TOLERANCE |
22 |
0.0043 |
| 93 |
FOOT DEFORMITY |
48 |
0.0043 |
| 94 |
DISCOMFORT |
264 |
0.0043 |
| 95 |
PULMONARY FIBROSIS |
82 |
0.0043 |
| 96 |
METAPLASIA |
2 |
0.0042 |
| 97 |
PSORIATIC ARTHROPATHY |
168 |
0.0041 |
| 98 |
JOINT DISLOCATION |
43 |
0.0041 |
| 99 |
VOCAL CORD DYSFUNCTION |
2 |
0.0041 |
| 100 |
AMPHETAMINES POSITIVE |
3 |
0.0040 |
| 101 |
ADENOTONSILLECTOMY |
1 |
0.0040 |
| 102 |
INFUSION RELATED REACTION |
263 |
0.0040 |
| 103 |
OBESITY |
63 |
0.0040 |
| 104 |
KNEE ARTHROPLASTY |
83 |
0.0039 |
| 105 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
176 |
0.0039 |
| 106 |
ULCER HAEMORRHAGE |
26 |
0.0038 |
| 107 |
IMPAIRED HEALING |
126 |
0.0038 |
| 108 |
ONYCHOMADESIS |
16 |
0.0038 |
| 109 |
GAIT INABILITY |
120 |
0.0036 |
| 110 |
BLOOD CHOLESTEROL INCREASED |
167 |
0.0036 |
| 111 |
ADMINISTRATION SITE ERYTHEMA |
1 |
0.0035 |
| 112 |
SINUS POLYP |
2 |
0.0035 |
| 113 |
SPINAL FUSION SURGERY |
14 |
0.0034 |
| 114 |
HEPATIC ENZYME INCREASED |
234 |
0.0034 |
| 115 |
MATERNAL EXPOSURE DURING PREGNANCY |
304 |
0.0034 |
| 116 |
THERAPEUTIC RESPONSE UNEXPECTED |
145 |
0.0032 |
| 117 |
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA |
1 |
0.0032 |
| 118 |
PERIORAL DERMATITIS |
2 |
0.0031 |
| 119 |
SWELLING |
294 |
0.0031 |
| 120 |
BLISTER |
173 |
0.0031 |
| 121 |
ADMINISTRATION SITE SWELLING |
1 |
0.0031 |
| 122 |
MITE ALLERGY |
2 |
0.0031 |
| 123 |
PRODUCT PACKAGING ISSUE |
29 |
0.0030 |
| 124 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
52 |
0.0030 |
| 125 |
ALLERGIC RESPIRATORY SYMPTOM |
1 |
0.0030 |
| 126 |
BENIGN NEOPLASM OF SKIN |
1 |
0.0030 |
| 127 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
11 |
0.0029 |
| 128 |
HEPATIC CIRRHOSIS |
55 |
0.0029 |
| 129 |
RHEUMATOID ARTHRITIS |
331 |
0.0029 |
| 130 |
PUSTULAR PSORIASIS |
10 |
0.0029 |
| 131 |
BASAL GANGLIA INFARCTION |
1 |
0.0029 |
| 132 |
ATHEROSCLEROSIS |
1 |
0.0029 |
| 133 |
PRODUCT BLISTER PACKAGING ISSUE |
3 |
0.0029 |
| 134 |
ASTHMA EXERCISE INDUCED |
1 |
0.0029 |
| 135 |
INFUSION SITE DISCHARGE |
5 |
0.0028 |
| 136 |
BRONCHIAL OBSTRUCTION |
4 |
0.0028 |
| 137 |
DRUG INTOLERANCE |
268 |
0.0028 |
| 138 |
FIBROCYSTIC BREAST DISEASE |
2 |
0.0027 |
| 139 |
PRODUCT LOT NUMBER ISSUE |
6 |
0.0027 |
| 140 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
7 |
0.0027 |
| 141 |
NASAL SEPTUM DEVIATION |
5 |
0.0026 |
| 142 |
OSTEOARTHRITIS |
108 |
0.0025 |
| 143 |
NIGHT SWEATS |
81 |
0.0025 |
| 144 |
TREATMENT FAILURE |
208 |
0.0025 |
| 145 |
EXCESSIVE GRANULATION TISSUE |
2 |
0.0025 |
| 146 |
HAND-FOOT-AND-MOUTH DISEASE |
2 |
0.0024 |
| 147 |
CSF PROTEIN INCREASED |
2 |
0.0024 |
| 148 |
COVID-19 IMMUNISATION |
2 |
0.0024 |
| 149 |
OEDEMA |
130 |
0.0024 |
| 150 |
PRODUCT USED FOR UNKNOWN INDICATION |
3 |
0.0024 |
| 151 |
EAR INFECTION |
63 |
0.0024 |
| 152 |
EAR PAIN |
46 |
0.0024 |
| 153 |
JOINT STIFFNESS |
62 |
0.0024 |
| 154 |
DELIRIUM |
82 |
0.0024 |
| 155 |
ROAD TRAFFIC ACCIDENT |
98 |
0.0023 |
| 156 |
ALLERGIC SINUSITIS |
2 |
0.0023 |
| 157 |
INJURY |
164 |
0.0023 |
| 158 |
LOWER RESPIRATORY TRACT INFECTION |
104 |
0.0023 |
| 159 |
WHEEZING |
135 |
0.0023 |
| 160 |
DISABILITY |
44 |
0.0022 |
| 161 |
RIGHT VENTRICULAR HYPERTROPHY |
2 |
0.0022 |
| 162 |
ALLERGY TO ARTHROPOD STING |
1 |
0.0022 |
| 163 |
ALLERGY TO PLANTS |
1 |
0.0022 |
| 164 |
NAIL DISORDER |
19 |
0.0022 |
| 165 |
ABULIA |
2 |
0.0022 |
| 166 |
STOMATITIS |
130 |
0.0021 |
| 167 |
PRODUCT EXPIRATION DATE ISSUE |
3 |
0.0021 |
| 168 |
THERAPEUTIC RESPONSE INCREASED |
2 |
0.0021 |
| 169 |
EPILEPSY |
65 |
0.0021 |
| 170 |
JOINT SWELLING |
256 |
0.0021 |
| 171 |
WEIGHT ABNORMAL |
5 |
0.0021 |
| 172 |
ABDOMINAL DISCOMFORT |
342 |
0.0020 |
| 173 |
THERAPY NON-RESPONDER |
91 |
0.0020 |
| 174 |
MOBILITY DECREASED |
141 |
0.0020 |
| 175 |
MUSCULOSKELETAL STIFFNESS |
171 |
0.0019 |
| 176 |
ACCIDENT AT HOME |
1 |
0.0019 |
| 177 |
PRE-EXISTING CONDITION IMPROVED |
12 |
0.0019 |
| 178 |
INTENTIONAL PRODUCT USE ISSUE |
166 |
0.0019 |
| 179 |
ALLERGY TO ANIMAL |
2 |
0.0019 |
| 180 |
RASH VESICULAR |
9 |
0.0019 |
| 181 |
PREGNANCY |
37 |
0.0018 |
| 182 |
C-REACTIVE PROTEIN INCREASED |
66 |
0.0018 |
| 183 |
NEPHROSCLEROSIS |
2 |
0.0018 |
| 184 |
MULTIPLE ALLERGIES |
14 |
0.0018 |
| 185 |
EXPOSURE VIA BREAST MILK |
7 |
0.0018 |
| 186 |
RADIATION SKIN INJURY |
2 |
0.0017 |
| 187 |
TASTE DISORDER |
35 |
0.0017 |
| 188 |
POLYARTHRITIS |
9 |
0.0017 |
| 189 |
ALOPECIA |
335 |
0.0017 |
| 190 |
LIVER FUNCTION TEST INCREASED |
36 |
0.0017 |
| 191 |
JOINT ARTHROPLASTY |
3 |
0.0017 |
| 192 |
EMBOLISM ARTERIAL |
2 |
0.0017 |
| 193 |
SINUSITIS |
169 |
0.0016 |
| 194 |
DRUG SCREEN POSITIVE |
13 |
0.0016 |
| 195 |
PRODUCT USE ISSUE |
307 |
0.0016 |
| 196 |
MUSCULOSKELETAL PAIN |
85 |
0.0016 |
| 197 |
LIVER DISORDER |
71 |
0.0016 |
| 198 |
NASAL PRURITUS |
2 |
0.0016 |
| 199 |
LUNG DISORDER |
78 |
0.0016 |
| 200 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
27 |
0.0016 |
| 201 |
ANAL INFLAMMATION |
1 |
0.0016 |
| 202 |
BACK INJURY |
17 |
0.0016 |
| 203 |
CONGENITAL ANOMALY |
12 |
0.0015 |
| 204 |
EXPOSURE DURING PREGNANCY |
96 |
0.0015 |
| 205 |
INFLAMMATION |
79 |
0.0015 |
| 206 |
DRY MOUTH |
124 |
0.0015 |
| 207 |
HYPERSENSITIVITY |
282 |
0.0015 |
| 208 |
SLEEP DISORDER |
107 |
0.0015 |
| 209 |
REBOUND ATOPIC DERMATITIS |
3 |
0.0015 |
| 210 |
PRODUCT LABEL ISSUE |
10 |
0.0015 |
| 211 |
NORMAL NEWBORN |
8 |
0.0015 |
| 212 |
UPPER RESPIRATORY TRACT INFECTION |
68 |
0.0015 |
| 213 |
CARBON DIOXIDE INCREASED |
2 |
0.0015 |
| 214 |
IMMUNOGLOBULINS DECREASED |
2 |
0.0015 |
| 215 |
NASAL DRYNESS |
9 |
0.0014 |
| 216 |
PHARYNGEAL ERYTHEMA |
3 |
0.0014 |
| 217 |
PELVIC VENOUS THROMBOSIS |
2 |
0.0014 |
| 218 |
BITE |
1 |
0.0014 |
| 219 |
GENERAL PHYSICAL HEALTH DETERIORATION |
160 |
0.0014 |
| 220 |
ALANINE AMINOTRANSFERASE DECREASED |
1 |
0.0014 |
| 221 |
MIGRAINE |
131 |
0.0014 |
| 222 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
2 |
0.0014 |
| 223 |
DRUG-INDUCED LIVER INJURY |
43 |
0.0014 |
| 224 |
ATROPHIC VULVOVAGINITIS |
1 |
0.0014 |
| 225 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
65 |
0.0014 |
| 226 |
ASTHMA |
152 |
0.0013 |
| 227 |
GASTROINTESTINAL DISORDER |
120 |
0.0013 |
| 228 |
RESPIRATORY DISORDER |
40 |
0.0013 |
| 229 |
CHRONIC SINUSITIS |
5 |
0.0013 |
| 230 |
MUSCLE SPASTICITY |
16 |
0.0013 |
| 231 |
ORAL MUCOSAL ERYTHEMA |
2 |
0.0013 |
| 232 |
INCORRECT DRUG ADMINISTRATION DURATION |
36 |
0.0013 |
| 233 |
DYSPEPSIA |
125 |
0.0013 |
| 234 |
CYSTITIS INTERSTITIAL |
2 |
0.0012 |
| 235 |
OSTEOPOROSIS |
51 |
0.0012 |
| 236 |
ILL-DEFINED DISORDER |
75 |
0.0012 |
| 237 |
OPTIC ATROPHY |
2 |
0.0012 |
| 238 |
INTESTINAL POLYP |
2 |
0.0012 |
| 239 |
INFUSION SITE HAEMORRHAGE |
4 |
0.0012 |
| 240 |
AMNESIA |
78 |
0.0012 |
| 241 |
EYELID IRRITATION |
3 |
0.0012 |
| 242 |
BILIARY DYSKINESIA |
2 |
0.0012 |
| 243 |
INCREASED BRONCHIAL SECRETION |
3 |
0.0012 |
| 244 |
LACTOSE INTOLERANCE |
3 |
0.0012 |
| 245 |
CONTUSION |
112 |
0.0012 |
| 246 |
HYPOAESTHESIA |
174 |
0.0012 |
| 247 |
ADVERSE EVENT |
107 |
0.0012 |
| 248 |
HYPERTRANSAMINASAEMIA |
8 |
0.0011 |
| 249 |
VERTIGO POSITIONAL |
2 |
0.0011 |
| 250 |
PRODUCT USE IN UNAPPROVED INDICATION |
280 |
0.0011 |
| 251 |
SKIN WEEPING |
4 |
0.0011 |
| 252 |
MYOSITIS |
10 |
0.0011 |
| 253 |
MONOCYTE COUNT INCREASED |
4 |
0.0011 |
| 254 |
URTICARIA |
182 |
0.0011 |
| 255 |
BIOPSY |
1 |
0.0011 |
| 256 |
DRUG ADMINISTRATION ERROR |
33 |
0.0011 |
| 257 |
HYPERTENSIVE HEART DISEASE |
2 |
0.0011 |
| 258 |
POOR QUALITY SLEEP |
23 |
0.0011 |
| 259 |
SOMNAMBULISM |
7 |
0.0011 |
| 260 |
PARANASAL SINUS DISCOMFORT |
4 |
0.0011 |
| 261 |
PANCREATIC CARCINOMA METASTATIC |
3 |
0.0011 |
| 262 |
HYPERCOAGULATION |
2 |
0.0010 |
| 263 |
PARANASAL SINUS HYPERSECRETION |
4 |
0.0010 |
| 264 |
ANTINUCLEAR ANTIBODY INCREASED |
1 |
0.0010 |
| 265 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
74 |
0.0010 |
| 266 |
BLADDER CATHETERISATION |
1 |
0.0010 |
| 267 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
4 |
0.0010 |
| 268 |
ANTIBIOTIC THERAPY |
1 |
0.0010 |
| 269 |
ENERGY INCREASED |
6 |
0.0010 |
| 270 |
INFECTION |
147 |
0.0010 |
| 271 |
ADVERSE DRUG REACTION |
91 |
0.0010 |
| 272 |
REBOUND ACID HYPERSECRETION |
3 |
0.0010 |
| 273 |
THERAPEUTIC RESPONSE DECREASED |
60 |
0.0010 |
| 274 |
AUTONOMIC NEUROPATHY |
1 |
0.0010 |
| 275 |
HYPERPARATHYROIDISM |
2 |
0.0010 |
| 276 |
NASOPHARYNGITIS |
177 |
0.0010 |
| 277 |
BLOOD BLISTER |
3 |
0.0010 |
| 278 |
FOETAL DISTRESS SYNDROME |
2 |
0.0009 |
| 279 |
PERIPHERAL SWELLING |
144 |
0.0009 |
| 280 |
GENERAL SYMPTOM |
7 |
0.0009 |
| 281 |
BRONCHITIS |
69 |
0.0009 |
| 282 |
JAW FRACTURE |
2 |
0.0009 |
| 283 |
BLADDER DILATATION |
1 |
0.0009 |
| 284 |
ACARODERMATITIS |
1 |
0.0009 |
| 285 |
ONYCHOMYCOSIS |
4 |
0.0009 |
| 286 |
SINUS DISORDER |
18 |
0.0009 |
| 287 |
MIDDLE EAR EFFUSION |
2 |
0.0009 |
| 288 |
ADRENAL INSUFFICIENCY |
11 |
0.0009 |
| 289 |
FEELING JITTERY |
17 |
0.0009 |
| 290 |
GASTRIC POLYPS |
2 |
0.0009 |
| 291 |
ARTERIAL HAEMORRHAGE |
1 |
0.0009 |
| 292 |
IMPLANT SITE INFECTION |
2 |
0.0009 |
| 293 |
SINUS PAIN |
2 |
0.0009 |
| 294 |
ALLODYNIA |
1 |
0.0009 |
| 295 |
MUSCLE CONTRACTIONS INVOLUNTARY |
3 |
0.0009 |
| 296 |
HANGOVER |
3 |
0.0009 |
| 297 |
SEASONAL ALLERGY |
12 |
0.0008 |
| 298 |
BILE DUCT CANCER |
1 |
0.0008 |
| 299 |
URINE FLOW DECREASED |
2 |
0.0008 |
| 300 |
RASH |
362 |
0.0008 |
| 301 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
59 |
0.0008 |
| 302 |
STARING |
2 |
0.0008 |
| 303 |
BREATH ODOUR |
2 |
0.0008 |
| 304 |
IMMUNODEFICIENCY |
12 |
0.0008 |
| 305 |
HYPERPARATHYROIDISM SECONDARY |
2 |
0.0008 |
| 306 |
HYPERTENSION |
169 |
0.0008 |
| 307 |
MUSCULAR WEAKNESS |
90 |
0.0008 |
| 308 |
ENDODONTIC PROCEDURE |
2 |
0.0008 |
| 309 |
EXPIRED PRODUCT ADMINISTERED |
26 |
0.0008 |
| 310 |
ABDOMINAL PAIN UPPER |
160 |
0.0008 |
| 311 |
MENOPAUSE |
2 |
0.0008 |
| 312 |
ANAEMIA POSTOPERATIVE |
1 |
0.0008 |
| 313 |
NASAL DISORDER |
2 |
0.0008 |
| 314 |
LOW TURNOVER OSTEOPATHY |
3 |
0.0008 |
| 315 |
ABDOMINAL MASS |
2 |
0.0007 |
| 316 |
CONDITION AGGRAVATED |
227 |
0.0007 |
| 317 |
WEIGHT BEARING DIFFICULTY |
2 |
0.0007 |
| 318 |
STRESS FRACTURE |
4 |
0.0007 |
| 319 |
DERMATITIS ATOPIC |
39 |
0.0007 |
| 320 |
ORAL FUNGAL INFECTION |
2 |
0.0007 |
| 321 |
ONYCHOCLASIS |
5 |
0.0007 |
| 322 |
CONFUSIONAL STATE |
117 |
0.0007 |
| 323 |
DRUG SCREEN FALSE POSITIVE |
2 |
0.0007 |
| 324 |
CYSTIC FIBROSIS |
4 |
0.0007 |
| 325 |
OEDEMA PERIPHERAL |
88 |
0.0007 |
| 326 |
THERAPEUTIC RESPONSE DELAYED |
2 |
0.0007 |
| 327 |
COELIAC DISEASE |
7 |
0.0007 |
| 328 |
CHEST PAIN |
131 |
0.0007 |
| 329 |
FORCED EXPIRATORY VOLUME DECREASED |
2 |
0.0007 |
| 330 |
INCORRECT DRUG ADMINISTRATION RATE |
3 |
0.0007 |
| 331 |
SHOULDER OPERATION |
3 |
0.0007 |
| 332 |
UPPER RESPIRATORY TRACT CONGESTION |
2 |
0.0007 |
| 333 |
DYSPNOEA AT REST |
2 |
0.0007 |
| 334 |
ARTHRITIS |
54 |
0.0007 |
| 335 |
GINGIVAL SWELLING |
3 |
0.0007 |
| 336 |
MEMORY IMPAIRMENT |
93 |
0.0007 |
| 337 |
BACK DISORDER |
11 |
0.0007 |
| 338 |
RHINITIS ALLERGIC |
3 |
0.0007 |
| 339 |
SINUS HEADACHE |
4 |
0.0007 |
| 340 |
AXILLARY PAIN |
1 |
0.0007 |
| 341 |
COLITIS ULCERATIVE |
30 |
0.0007 |
| 342 |
GASTROOESOPHAGEAL REFLUX DISEASE |
54 |
0.0007 |
| 343 |
PAIN |
409 |
0.0007 |
| 344 |
SUSPECTED OFF LABEL USE |
3 |
0.0007 |
| 345 |
CENTRAL VENOUS CATHETERISATION |
2 |
0.0007 |
| 346 |
DECREASED APPETITE |
153 |
0.0007 |
| 347 |
WEIGHT INCREASED |
146 |
0.0007 |
| 348 |
PHARYNGITIS STREPTOCOCCAL |
7 |
0.0006 |
| 349 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 350 |
SKIN TIGHTNESS |
3 |
0.0006 |
| 351 |
INSOMNIA |
169 |
0.0006 |
| 352 |
INFUSION SITE PRURITUS |
2 |
0.0006 |
| 353 |
SPINAL DISORDER |
6 |
0.0006 |
| 354 |
RESPIRATORY TRACT CONGESTION |
10 |
0.0006 |
| 355 |
SLEEP APNOEA SYNDROME |
12 |
0.0006 |
| 356 |
GAIT DISTURBANCE |
119 |
0.0006 |
| 357 |
SKIN EROSION |
2 |
0.0006 |
| 358 |
RHINITIS |
5 |
0.0006 |
| 359 |
CARDIAC FLUTTER |
4 |
0.0006 |
| 360 |
DIZZINESS POSTURAL |
6 |
0.0006 |
| 361 |
PARAESTHESIA |
97 |
0.0006 |
| 362 |
PHARYNGEAL SWELLING |
6 |
0.0006 |
| 363 |
ECZEMA |
32 |
0.0006 |
| 364 |
MEDICATION ERROR |
33 |
0.0006 |
| 365 |
VISUAL IMPAIRMENT |
73 |
0.0006 |
| 366 |
HEPATIC CYST |
2 |
0.0006 |
| 367 |
INITIAL INSOMNIA |
6 |
0.0006 |
| 368 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
32 |
0.0006 |
| 369 |
REGURGITATION |
2 |
0.0006 |
| 370 |
ACUTE SINUSITIS |
1 |
0.0006 |
| 371 |
SNEEZING |
13 |
0.0006 |
| 372 |
GRANULOMA |
2 |
0.0006 |
| 373 |
TACHYPHRENIA |
2 |
0.0006 |
| 374 |
ANXIETY |
163 |
0.0006 |
| 375 |
THROMBOPHLEBITIS |
2 |
0.0006 |
| 376 |
SCRATCH |
6 |
0.0006 |
| 377 |
HAND FRACTURE |
4 |
0.0006 |
| 378 |
SKIN FISSURES |
11 |
0.0006 |
| 379 |
PRURITUS |
214 |
0.0006 |
| 380 |
BONE LESION |
2 |
0.0006 |
| 381 |
ARTHRALGIA |
229 |
0.0006 |
| 382 |
WITHDRAWAL SYNDROME |
23 |
0.0005 |
| 383 |
NONSPECIFIC REACTION |
3 |
0.0005 |
| 384 |
SKIN HAEMORRHAGE |
8 |
0.0005 |
| 385 |
TENDON INJURY |
2 |
0.0005 |
| 386 |
NEURODERMATITIS |
2 |
0.0005 |
| 387 |
BLOOD CHOLESTEROL DECREASED |
1 |
0.0005 |
| 388 |
RETINOPATHY |
2 |
0.0005 |
| 389 |
FATIGUE |
417 |
0.0005 |
| 390 |
BLADDER SPASM |
1 |
0.0005 |
| 391 |
PERIORBITAL SWELLING |
3 |
0.0005 |
| 392 |
PAROSMIA |
4 |
0.0005 |
| 393 |
FACE INJURY |
2 |
0.0005 |
| 394 |
ARTERIAL DISORDER |
1 |
0.0005 |
| 395 |
COMMUNICATION DISORDER |
2 |
0.0005 |
| 396 |
ADRENAL DISORDER |
1 |
0.0005 |
| 397 |
HYPERVENTILATION |
3 |
0.0005 |
| 398 |
PRODUCT LABEL CONFUSION |
3 |
0.0005 |
| 399 |
RHINOVIRUS INFECTION |
2 |
0.0005 |
| 400 |
VITAMIN D DEFICIENCY |
5 |
0.0005 |
| 401 |
VIRAL INFECTION |
17 |
0.0005 |
| 402 |
BRAIN FOG |
8 |
0.0005 |
| 403 |
URINE ODOUR ABNORMAL |
3 |
0.0005 |
| 404 |
DEPRESSION |
116 |
0.0005 |
| 405 |
PRODUCT ADMINISTRATION INTERRUPTED |
4 |
0.0005 |
| 406 |
DECREASED INTEREST |
3 |
0.0005 |
| 407 |
MUSCLE SPASMS |
93 |
0.0005 |
| 408 |
EYE PRURITUS |
17 |
0.0005 |
| 409 |
ANORECTAL DISORDER |
1 |
0.0005 |
| 410 |
CANDIDIASIS |
2 |
0.0005 |
| 411 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
2 |
0.0005 |
| 412 |
TOOTH ABSCESS |
5 |
0.0005 |
| 413 |
UPPER-AIRWAY COUGH SYNDROME |
4 |
0.0005 |
| 414 |
CONJUNCTIVITIS |
9 |
0.0005 |
| 415 |
PHARYNGITIS |
6 |
0.0005 |
| 416 |
ANOSMIA |
7 |
0.0005 |
| 417 |
PSYCHOMOTOR HYPERACTIVITY |
8 |
0.0005 |
| 418 |
PRODUCTIVE COUGH |
23 |
0.0005 |
| 419 |
RED CELL DISTRIBUTION WIDTH INCREASED |
2 |
0.0005 |
| 420 |
TENDERNESS |
5 |
0.0005 |
| 421 |
WEIGHT FLUCTUATION |
5 |
0.0005 |
| 422 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
2 |
0.0005 |
| 423 |
INTERVERTEBRAL DISC DISORDER |
2 |
0.0005 |
| 424 |
VITAMIN D DECREASED |
4 |
0.0005 |
| 425 |
PROCTALGIA |
3 |
0.0005 |
| 426 |
HEREDITARY ANGIOEDEMA |
5 |
0.0005 |
| 427 |
LACRIMATION INCREASED |
14 |
0.0005 |
| 428 |
MUSCLE STRAIN |
4 |
0.0005 |
| 429 |
RESPIRATORY TRACT INFECTION |
12 |
0.0005 |
| 430 |
BONE CANCER |
2 |
0.0005 |
| 431 |
DIVERTICULUM INTESTINAL |
2 |
0.0005 |
| 432 |
PULMONARY FUNCTION TEST DECREASED |
2 |
0.0005 |
| 433 |
BIPOLAR I DISORDER |
1 |
0.0005 |
| 434 |
SPINAL OSTEOARTHRITIS |
4 |
0.0005 |
| 435 |
PAIN IN EXTREMITY |
133 |
0.0005 |
| 436 |
SKIN MASS |
3 |
0.0004 |
| 437 |
WRONG DRUG ADMINISTERED |
4 |
0.0004 |
| 438 |
TERMINAL STATE |
3 |
0.0004 |
| 439 |
SOMNOLENCE |
90 |
0.0004 |
| 440 |
OFF LABEL USE |
390 |
0.0004 |
| 441 |
URINARY TRACT DISORDER |
2 |
0.0004 |
| 442 |
THROAT TIGHTNESS |
12 |
0.0004 |
| 443 |
DRY EYE |
22 |
0.0004 |
| 444 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
3 |
0.0004 |
| 445 |
TREATMENT NONCOMPLIANCE |
24 |
0.0004 |
| 446 |
DIZZINESS |
216 |
0.0004 |
| 447 |
LOCALISED OEDEMA |
2 |
0.0004 |
| 448 |
NEPHROGENIC ANAEMIA |
2 |
0.0004 |
| 449 |
FEELING OF DESPAIR |
2 |
0.0004 |
| 450 |
DRUG INEFFECTIVE |
565 |
0.0004 |
| 451 |
APPENDICITIS |
4 |
0.0004 |
| 452 |
PYREXIA |
148 |
0.0004 |
| 453 |
TACHYCARDIA |
38 |
0.0004 |
| 454 |
VAGINAL INFECTION |
2 |
0.0004 |
| 455 |
SKIN ABRASION |
2 |
0.0004 |
| 456 |
SARCOIDOSIS |
2 |
0.0004 |
| 457 |
PRE-ECLAMPSIA |
2 |
0.0004 |
| 458 |
MEDICATION RESIDUE PRESENT |
2 |
0.0004 |
| 459 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
3 |
0.0004 |
| 460 |
VOMITING |
195 |
0.0004 |
| 461 |
HEADACHE |
259 |
0.0004 |
| 462 |
FINGER DEFORMITY |
2 |
0.0004 |
| 463 |
NOCTURIA |
5 |
0.0004 |
| 464 |
UTERINE LEIOMYOMA |
3 |
0.0004 |
| 465 |
HORMONE LEVEL ABNORMAL |
2 |
0.0004 |
| 466 |
ORAL DISORDER |
3 |
0.0004 |
| 467 |
INFLAMMATORY BOWEL DISEASE |
4 |
0.0004 |
| 468 |
FREQUENT BOWEL MOVEMENTS |
11 |
0.0004 |
| 469 |
PSORIASIS |
53 |
0.0004 |
| 470 |
HYPERVOLAEMIA |
2 |
0.0004 |
| 471 |
FEELING DRUNK |
3 |
0.0004 |
| 472 |
RHINORRHOEA |
26 |
0.0004 |
| 473 |
PNEUMONIA |
130 |
0.0004 |
| 474 |
UNDERDOSE |
29 |
0.0004 |
| 475 |
RECTAL HAEMORRHAGE |
17 |
0.0004 |
| 476 |
ABDOMINAL PAIN |
92 |
0.0004 |
| 477 |
PATHOLOGICAL FRACTURE |
2 |
0.0004 |
| 478 |
INSURANCE ISSUE |
6 |
0.0004 |
| 479 |
NASAL CONGESTION |
23 |
0.0004 |
| 480 |
DRY SKIN |
52 |
0.0004 |
| 481 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
70 |
0.0004 |
| 482 |
ILLNESS |
40 |
0.0004 |
| 483 |
GASTROENTERITIS VIRAL |
7 |
0.0004 |
| 484 |
CONCUSSION |
3 |
0.0004 |
| 485 |
PALPITATIONS |
45 |
0.0004 |
| 486 |
APLASTIC ANAEMIA |
2 |
0.0004 |
| 487 |
SENSITIVITY TO WEATHER CHANGE |
2 |
0.0004 |
| 488 |
ANKYLOSING SPONDYLITIS |
5 |
0.0004 |
| 489 |
NECK PAIN |
21 |
0.0004 |
| 490 |
ANIMAL BITE |
1 |
0.0004 |
| 491 |
FEELING HOT |
23 |
0.0004 |
| 492 |
DYSPNOEA |
212 |
0.0004 |
| 493 |
FOOD POISONING |
2 |
0.0004 |
| 494 |
ANAESTHETIC COMPLICATION |
1 |
0.0004 |
| 495 |
SINUS CONGESTION |
5 |
0.0004 |
| 496 |
WEIGHT DECREASED |
103 |
0.0004 |
| 497 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
2 |
0.0004 |
| 498 |
HYDROCEPHALUS |
2 |
0.0004 |
| 499 |
ASPIRATION |
4 |
0.0004 |
| 500 |
TOOTH FRACTURE |
4 |
0.0004 |
| 501 |
CHOKING SENSATION |
2 |
0.0004 |
| 502 |
INJECTION SITE INJURY |
2 |
0.0004 |
| 503 |
OCULAR HYPERAEMIA |
17 |
0.0004 |
| 504 |
MALAISE |
157 |
0.0004 |
| 505 |
ANAL HAEMORRHAGE |
1 |
0.0004 |
| 506 |
SKIN INFECTION |
4 |
0.0004 |
| 507 |
INFUSION SITE ERYTHEMA |
3 |
0.0004 |
| 508 |
SKIN EXFOLIATION |
30 |
0.0004 |
| 509 |
SKIN REACTION |
5 |
0.0004 |
| 510 |
CARDIAC VALVE DISEASE |
2 |
0.0003 |
| 511 |
SPINAL FRACTURE |
7 |
0.0003 |
| 512 |
IMPAIRED QUALITY OF LIFE |
5 |
0.0003 |
| 513 |
EXPOSURE VIA SKIN CONTACT |
9 |
0.0003 |
| 514 |
ASTHENIA |
130 |
0.0003 |
| 515 |
COVID-19 PNEUMONIA |
4 |
0.0003 |
| 516 |
ODYNOPHAGIA |
2 |
0.0003 |
| 517 |
ATYPICAL PNEUMONIA |
1 |
0.0003 |
| 518 |
SYMPTOM RECURRENCE |
2 |
0.0003 |
| 519 |
WRIST FRACTURE |
4 |
0.0003 |
| 520 |
RESTLESS LEGS SYNDROME |
6 |
0.0003 |
| 521 |
INCREASED TENDENCY TO BRUISE |
3 |
0.0003 |
| 522 |
MENISCUS INJURY |
2 |
0.0003 |
| 523 |
INTERVERTEBRAL DISC DEGENERATION |
3 |
0.0003 |
| 524 |
INCORRECT DOSE ADMINISTERED |
74 |
0.0003 |
| 525 |
PRODUCT DISTRIBUTION ISSUE |
3 |
0.0003 |
| 526 |
TENDONITIS |
5 |
0.0003 |
| 527 |
SCOLIOSIS |
2 |
0.0003 |
| 528 |
INFUSION SITE EXTRAVASATION |
2 |
0.0003 |
| 529 |
MIDDLE INSOMNIA |
6 |
0.0003 |
| 530 |
INTERVERTEBRAL DISC PROTRUSION |
7 |
0.0003 |
| 531 |
FLANK PAIN |
3 |
0.0003 |
| 532 |
PHOTOPHOBIA |
6 |
0.0003 |
| 533 |
INFUSION SITE SWELLING |
2 |
0.0003 |
| 534 |
DIARRHOEA |
205 |
0.0003 |
| 535 |
BLADDER PAIN |
1 |
0.0003 |
| 536 |
TOOTH DISORDER |
7 |
0.0003 |
| 537 |
THROAT IRRITATION |
14 |
0.0003 |
| 538 |
POOR QUALITY DRUG ADMINISTERED |
2 |
0.0003 |
| 539 |
MUSCLE TIGHTNESS |
5 |
0.0003 |
| 540 |
ANTINUCLEAR ANTIBODY POSITIVE |
1 |
0.0003 |
| 541 |
DEEP VEIN THROMBOSIS |
20 |
0.0003 |
| 542 |
KNEE OPERATION |
3 |
0.0003 |
| 543 |
TOOTH INFECTION |
4 |
0.0003 |
| 544 |
HYPOKALAEMIA |
14 |
0.0003 |
| 545 |
PRODUCT QUALITY ISSUE |
41 |
0.0003 |
| 546 |
APPETITE DISORDER |
2 |
0.0003 |
| 547 |
CHOLECYSTITIS CHRONIC |
2 |
0.0003 |
| 548 |
QUALITY OF LIFE DECREASED |
4 |
0.0003 |
| 549 |
BREAST MASS |
2 |
0.0003 |
| 550 |
FULL BLOOD COUNT DECREASED |
6 |
0.0003 |
| 551 |
EXTRA DOSE ADMINISTERED |
12 |
0.0003 |
| 552 |
WRONG PRODUCT ADMINISTERED |
2 |
0.0003 |
| 553 |
FLUID RETENTION |
15 |
0.0003 |
| 554 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
2 |
0.0003 |
| 555 |
ABNORMAL LOSS OF WEIGHT |
2 |
0.0003 |
| 556 |
EUPHORIC MOOD |
3 |
0.0003 |
| 557 |
EAR DISCOMFORT |
3 |
0.0003 |
| 558 |
ABNORMAL DREAMS |
8 |
0.0003 |
| 559 |
HAIR GROWTH ABNORMAL |
2 |
0.0003 |
| 560 |
WHITE BLOOD CELL COUNT INCREASED |
11 |
0.0003 |
| 561 |
APHONIA |
4 |
0.0003 |
| 562 |
NAUSEA |
226 |
0.0003 |
| 563 |
RIGHT VENTRICULAR FAILURE |
2 |
0.0003 |
| 564 |
INJECTION SITE URTICARIA |
7 |
0.0003 |
| 565 |
CLOSTRIDIUM DIFFICILE COLITIS |
3 |
0.0003 |
| 566 |
PRODUCT DOSE OMISSION IN ERROR |
8 |
0.0003 |
| 567 |
RETINAL HAEMORRHAGE |
2 |
0.0003 |
| 568 |
APPENDICECTOMY |
1 |
0.0003 |
| 569 |
GALLBLADDER DISORDER |
5 |
0.0003 |
| 570 |
VERTIGO |
17 |
0.0003 |
| 571 |
APPARENT DEATH |
1 |
0.0003 |
| 572 |
TONGUE DISORDER |
2 |
0.0003 |
| 573 |
DRUG EFFECT INCOMPLETE |
10 |
0.0003 |
| 574 |
OESOPHAGITIS |
3 |
0.0003 |
| 575 |
BONE DISORDER |
5 |
0.0003 |
| 576 |
LIQUID PRODUCT PHYSICAL ISSUE |
2 |
0.0003 |
| 577 |
MAJOR DEPRESSION |
2 |
0.0003 |
| 578 |
CHEST DISCOMFORT |
28 |
0.0003 |
| 579 |
SENSITIVE SKIN |
2 |
0.0003 |
| 580 |
OBSTRUCTIVE AIRWAYS DISORDER |
3 |
0.0003 |
| 581 |
THINKING ABNORMAL |
5 |
0.0003 |
| 582 |
SUNBURN |
2 |
0.0003 |
| 583 |
OCULAR DISCOMFORT |
3 |
0.0003 |
| 584 |
EYE INFECTION |
3 |
0.0003 |
| 585 |
REBOUND EFFECT |
3 |
0.0003 |
| 586 |
PANCREATITIS |
14 |
0.0003 |
| 587 |
TENDON PAIN |
2 |
0.0003 |
| 588 |
IMPAIRED DRIVING ABILITY |
3 |
0.0003 |
| 589 |
FOOT FRACTURE |
5 |
0.0003 |
| 590 |
DERMATITIS CONTACT |
3 |
0.0003 |
| 591 |
HEART RATE INCREASED |
26 |
0.0003 |
| 592 |
RENAL FAILURE CHRONIC |
2 |
0.0003 |
| 593 |
FOOD ALLERGY |
2 |
0.0003 |
| 594 |
RASH PRURITIC |
14 |
0.0003 |
| 595 |
CHOKING |
5 |
0.0003 |
| 596 |
ORAL HERPES |
5 |
0.0003 |
| 597 |
MENORRHAGIA |
5 |
0.0003 |
| 598 |
PRODUCT USE COMPLAINT |
4 |
0.0003 |
| 599 |
COUGH |
71 |
0.0003 |
| 600 |
BLOOD ALBUMIN DECREASED |
2 |
0.0003 |
| 601 |
RENAL CYST |
2 |
0.0003 |
| 602 |
TRICUSPID VALVE INCOMPETENCE |
2 |
0.0003 |
| 603 |
ACCIDENT |
3 |
0.0003 |
| 604 |
UPPER LIMB FRACTURE |
5 |
0.0003 |
| 605 |
FEELING ABNORMAL |
60 |
0.0003 |
| 606 |
BLOOD PRESSURE FLUCTUATION |
6 |
0.0002 |
| 607 |
TRANSPLANT REJECTION |
2 |
0.0002 |
| 608 |
BLEPHARITIS |
1 |
0.0002 |
| 609 |
OBSESSIVE-COMPULSIVE DISORDER |
2 |
0.0002 |
| 610 |
PRODUCT ADMINISTRATION ERROR |
5 |
0.0002 |
| 611 |
NEURALGIA |
6 |
0.0002 |
| 612 |
POST PROCEDURAL INFECTION |
2 |
0.0002 |
| 613 |
RIB FRACTURE |
5 |
0.0002 |
| 614 |
TENDON RUPTURE |
3 |
0.0002 |
| 615 |
SPINAL COMPRESSION FRACTURE |
2 |
0.0002 |
| 616 |
ACCIDENTAL EXPOSURE |
1 |
0.0002 |
| 617 |
LEUKOPENIA |
12 |
0.0002 |
| 618 |
INTENTIONAL PRODUCT MISUSE |
21 |
0.0002 |
| 619 |
DERMATITIS |
5 |
0.0002 |
| 620 |
DRUG USE DISORDER |
2 |
0.0002 |
| 621 |
SENSATION OF FOREIGN BODY |
2 |
0.0002 |
| 622 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 623 |
MUSCULOSKELETAL DISCOMFORT |
4 |
0.0002 |
| 624 |
HIATUS HERNIA |
3 |
0.0002 |
| 625 |
DIPLOPIA |
6 |
0.0002 |
| 626 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
2 |
0.0002 |
| 627 |
RASH MACULAR |
8 |
0.0002 |
| 628 |
URINE OUTPUT DECREASED |
2 |
0.0002 |
| 629 |
EOSINOPHILIA |
4 |
0.0002 |
| 630 |
INJECTION SITE RASH |
7 |
0.0002 |
| 631 |
GROIN PAIN |
2 |
0.0002 |
| 632 |
OROPHARYNGEAL PAIN |
21 |
0.0002 |
| 633 |
LUNG INFILTRATION |
2 |
0.0002 |
| 634 |
CHRONIC KIDNEY DISEASE |
17 |
0.0002 |
| 635 |
ORAL PAIN |
5 |
0.0002 |
| 636 |
SURGERY |
13 |
0.0002 |
| 637 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 638 |
OSTEOMYELITIS |
4 |
0.0002 |
| 639 |
OPTIC NEURITIS |
2 |
0.0002 |
| 640 |
IMPAIRED GASTRIC EMPTYING |
3 |
0.0002 |
| 641 |
ACCIDENTAL OVERDOSE |
8 |
0.0002 |
| 642 |
RESTLESSNESS |
8 |
0.0002 |
| 643 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
2 |
0.0002 |
| 644 |
BREAST CANCER STAGE I |
2 |
0.0002 |
| 645 |
POLLAKIURIA |
9 |
0.0002 |
| 646 |
HOSPITALISATION |
33 |
0.0002 |
| 647 |
EPISTAXIS |
16 |
0.0002 |
| 648 |
EYE PAIN |
12 |
0.0002 |
| 649 |
LACERATION |
2 |
0.0002 |
| 650 |
SQUAMOUS CELL CARCINOMA |
2 |
0.0002 |
| 651 |
THERAPEUTIC RESPONSE SHORTENED |
7 |
0.0002 |
| 652 |
SPUTUM DISCOLOURED |
2 |
0.0002 |
| 653 |
BRONCHOSPASM |
3 |
0.0002 |
| 654 |
RED BLOOD CELL COUNT DECREASED |
6 |
0.0002 |
| 655 |
PARAESTHESIA ORAL |
3 |
0.0002 |
| 656 |
ACUTE RESPIRATORY FAILURE |
4 |
0.0002 |
| 657 |
HYPERTHYROIDISM |
3 |
0.0002 |
| 658 |
ATELECTASIS |
2 |
0.0002 |
| 659 |
ACCIDENTAL EXPOSURE TO PRODUCT |
21 |
0.0002 |
| 660 |
THERAPY CHANGE |
2 |
0.0002 |
| 661 |
LABORATORY TEST ABNORMAL |
6 |
0.0002 |
| 662 |
URINARY INCONTINENCE |
6 |
0.0002 |
| 663 |
LIGAMENT SPRAIN |
2 |
0.0002 |
| 664 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
4 |
0.0002 |
| 665 |
CATARACT |
12 |
0.0002 |
| 666 |
BLADDER DISORDER |
2 |
0.0002 |
| 667 |
PULMONARY MASS |
3 |
0.0002 |
| 668 |
AGEUSIA |
5 |
0.0002 |
| 669 |
BRAIN INJURY |
2 |
0.0002 |
| 670 |
PRODUCT PHYSICAL ISSUE |
4 |
0.0002 |
| 671 |
OSTEOPENIA |
3 |
0.0002 |
| 672 |
DRY THROAT |
2 |
0.0002 |
| 673 |
VISION BLURRED |
27 |
0.0002 |
| 674 |
MOTOR DYSFUNCTION |
2 |
0.0002 |
| 675 |
HYPOPHAGIA |
5 |
0.0002 |
| 676 |
TEMPERATURE INTOLERANCE |
2 |
0.0002 |
| 677 |
BENIGN PROSTATIC HYPERPLASIA |
1 |
0.0002 |
| 678 |
PHARMACEUTICAL PRODUCT COMPLAINT |
5 |
0.0002 |
| 679 |
EYE DISCHARGE |
2 |
0.0002 |
| 680 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
39 |
0.0002 |
| 681 |
PULMONARY HYPERTENSION |
4 |
0.0002 |
| 682 |
NERVOUSNESS |
10 |
0.0002 |
| 683 |
PRODUCT DOSE OMISSION ISSUE |
56 |
0.0002 |
| 684 |
DYSURIA |
7 |
0.0002 |
| 685 |
ERYTHEMA |
39 |
0.0002 |
| 686 |
BACK PAIN |
44 |
0.0002 |
| 687 |
INCONTINENCE |
2 |
0.0002 |
| 688 |
DISEASE RECURRENCE |
9 |
0.0002 |
| 689 |
INFLUENZA |
21 |
0.0002 |
| 690 |
EYE SWELLING |
7 |
0.0002 |
| 691 |
ABSCESS |
3 |
0.0002 |
| 692 |
INJECTION SITE BRUISING |
15 |
0.0002 |
| 693 |
DISTURBANCE IN ATTENTION |
10 |
0.0002 |
| 694 |
OVERDOSE |
40 |
0.0002 |
| 695 |
DECREASED ACTIVITY |
2 |
0.0002 |
| 696 |
PRURITUS GENERALISED |
4 |
0.0002 |
| 697 |
SKIN LACERATION |
2 |
0.0002 |
| 698 |
ASTHENOPIA |
1 |
0.0002 |
| 699 |
PHOTOSENSITIVITY REACTION |
3 |
0.0002 |
| 700 |
DIVERTICULITIS |
5 |
0.0002 |
| 701 |
LIP SWELLING |
6 |
0.0002 |
| 702 |
FUNGAL INFECTION |
6 |
0.0002 |
| 703 |
HAEMOPTYSIS |
5 |
0.0002 |
| 704 |
BLOOD CALCIUM DECREASED |
2 |
0.0002 |
| 705 |
CHROMATURIA |
4 |
0.0002 |
| 706 |
COVID-19 |
31 |
0.0002 |
| 707 |
BLOOD PRESSURE INCREASED |
27 |
0.0002 |
| 708 |
INTENTIONAL DOSE OMISSION |
5 |
0.0002 |
| 709 |
CHOLECYSTECTOMY |
2 |
0.0002 |
| 710 |
HYPERSOMNIA |
5 |
0.0002 |
| 711 |
DYSSTASIA |
5 |
0.0002 |
| 712 |
METASTASES TO LIVER |
3 |
0.0002 |
| 713 |
DEPRESSED MOOD |
9 |
0.0002 |
| 714 |
URINARY TRACT INFECTION |
29 |
0.0002 |
| 715 |
LYMPHADENOPATHY |
6 |
0.0002 |
| 716 |
HEAD DISCOMFORT |
3 |
0.0002 |
| 717 |
DYSPHAGIA |
16 |
0.0002 |
| 718 |
MACULAR DEGENERATION |
2 |
0.0002 |
| 719 |
HYPERLIPIDAEMIA |
2 |
0.0002 |
| 720 |
RASH ERYTHEMATOUS |
8 |
0.0002 |
| 721 |
GOUT |
3 |
0.0002 |
| 722 |
IRRITABILITY |
10 |
0.0002 |
| 723 |
BLOOD POTASSIUM DECREASED |
5 |
0.0002 |
| 724 |
TOOTHACHE |
3 |
0.0002 |
| 725 |
SCHIZOPHRENIA |
2 |
0.0002 |
| 726 |
END STAGE RENAL DISEASE |
3 |
0.0002 |
| 727 |
INJECTION SITE PRURITUS |
11 |
0.0002 |
| 728 |
INJECTION SITE PAIN |
50 |
0.0002 |
| 729 |
GLOMERULAR FILTRATION RATE DECREASED |
2 |
0.0002 |
| 730 |
CARDIOMEGALY |
2 |
0.0002 |
| 731 |
CYST |
2 |
0.0002 |
| 732 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 733 |
TOOTH EXTRACTION |
2 |
0.0002 |
| 734 |
CONSTIPATION |
35 |
0.0002 |
| 735 |
PNEUMONIA ASPIRATION |
4 |
0.0002 |
| 736 |
SECRETION DISCHARGE |
2 |
0.0002 |
| 737 |
DYSPNOEA EXERTIONAL |
6 |
0.0002 |
| 738 |
CELLULITIS |
8 |
0.0002 |
| 739 |
BLOOD URINE PRESENT |
3 |
0.0002 |
| 740 |
MUSCLE ATROPHY |
2 |
0.0002 |
| 741 |
PULMONARY EMBOLISM |
15 |
0.0002 |
| 742 |
INCREASED APPETITE |
3 |
0.0002 |
| 743 |
GLAUCOMA |
3 |
0.0002 |
| 744 |
ROTATOR CUFF SYNDROME |
2 |
0.0002 |
| 745 |
INFUSION SITE PAIN |
2 |
0.0002 |
| 746 |
ANOREXIA |
2 |
0.0002 |
| 747 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
2 |
0.0002 |
| 748 |
INJECTION SITE INDURATION |
2 |
0.0002 |
| 749 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
8 |
0.0002 |
| 750 |
ABDOMINAL DISTENSION |
16 |
0.0002 |
| 751 |
KIDNEY INFECTION |
3 |
0.0002 |
| 752 |
SEDATION |
4 |
0.0002 |
| 753 |
TINNITUS |
7 |
0.0002 |
| 754 |
ANHEDONIA |
4 |
0.0002 |
| 755 |
EYE DISORDER |
5 |
0.0002 |
| 756 |
GASTRITIS |
4 |
0.0002 |
| 757 |
IMMUNE SYSTEM DISORDER |
2 |
0.0002 |
| 758 |
SARS-COV-2 TEST POSITIVE |
2 |
0.0002 |
| 759 |
BLOOD PRESSURE ABNORMAL |
3 |
0.0002 |
| 760 |
ADVERSE REACTION |
2 |
0.0002 |
| 761 |
HAIR TEXTURE ABNORMAL |
2 |
0.0001 |
| 762 |
MALIGNANT MELANOMA |
2 |
0.0001 |
| 763 |
THROMBOSIS |
12 |
0.0001 |
| 764 |
LOSS OF CONSCIOUSNESS |
19 |
0.0001 |
| 765 |
DYSGEUSIA |
11 |
0.0001 |
| 766 |
FLUSHING |
15 |
0.0001 |
| 767 |
LIMB INJURY |
4 |
0.0001 |
| 768 |
BODY TEMPERATURE INCREASED |
3 |
0.0001 |
| 769 |
PRODUCT PREPARATION ERROR |
3 |
0.0001 |
| 770 |
HOT FLUSH |
11 |
0.0001 |
| 771 |
SKIN LESION |
4 |
0.0001 |
| 772 |
HAEMATOCHEZIA |
8 |
0.0001 |
| 773 |
NIGHTMARE |
5 |
0.0001 |
| 774 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 775 |
FEELING COLD |
4 |
0.0001 |
| 776 |
HUNGER |
2 |
0.0001 |
| 777 |
CARPAL TUNNEL SYNDROME |
2 |
0.0001 |
| 778 |
BLOOD TEST ABNORMAL |
2 |
0.0001 |
| 779 |
HYPOXIA |
5 |
0.0001 |
| 780 |
PAIN IN JAW |
4 |
0.0001 |
| 781 |
FLATULENCE |
8 |
0.0001 |
| 782 |
RETCHING |
3 |
0.0001 |
| 783 |
JOINT INJURY |
3 |
0.0001 |
| 784 |
IMPAIRED WORK ABILITY |
3 |
0.0001 |
| 785 |
SKIN CANCER |
3 |
0.0001 |
| 786 |
BALANCE DISORDER |
12 |
0.0001 |
| 787 |
CLOSTRIDIUM DIFFICILE INFECTION |
3 |
0.0001 |
| 788 |
PANIC ATTACK |
5 |
0.0001 |
| 789 |
BONE PAIN |
8 |
0.0001 |
| 790 |
THERAPY CESSATION |
7 |
0.0001 |
| 791 |
FOETAL EXPOSURE DURING PREGNANCY |
11 |
0.0001 |
| 792 |
FALL |
45 |
0.0001 |
| 793 |
RENAL INJURY |
4 |
0.0001 |
| 794 |
SPEECH DISORDER |
7 |
0.0001 |
| 795 |
BONE LOSS |
2 |
0.0001 |
| 796 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 797 |
ECONOMIC PROBLEM |
2 |
0.0001 |
| 798 |
DEVICE FAILURE |
2 |
0.0001 |
| 799 |
SKIN IRRITATION |
6 |
0.0001 |
| 800 |
INJECTION SITE REACTION |
9 |
0.0001 |
| 801 |
EMOTIONAL DISORDER |
4 |
0.0001 |
| 802 |
LYMPHOMA |
2 |
0.0001 |
| 803 |
LIMB DISCOMFORT |
4 |
0.0001 |
| 804 |
FEMUR FRACTURE |
4 |
0.0001 |
| 805 |
LUNG INFECTION |
2 |
0.0001 |
| 806 |
THERAPY PARTIAL RESPONDER |
2 |
0.0001 |
| 807 |
BASAL CELL CARCINOMA |
2 |
0.0001 |
| 808 |
BONE DENSITY DECREASED |
4 |
0.0001 |
| 809 |
HEAD INJURY |
4 |
0.0001 |
| 810 |
PNEUMOTHORAX |
2 |
0.0001 |
| 811 |
PRODUCT PRESCRIBING ERROR |
3 |
0.0001 |
| 812 |
ULCER |
2 |
0.0001 |
| 813 |
CYSTITIS |
4 |
0.0001 |
| 814 |
MOOD SWINGS |
4 |
0.0001 |
| 815 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 816 |
BLOOD DISORDER |
1 |
0.0001 |
| 817 |
LOCALISED INFECTION |
3 |
0.0001 |
| 818 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 819 |
PRODUCT DOSE OMISSION |
8 |
0.0001 |
| 820 |
ABNORMAL FAECES |
1 |
0.0001 |
| 821 |
CHOLELITHIASIS |
4 |
0.0001 |
| 822 |
MULTIPLE FRACTURES |
2 |
0.0001 |
| 823 |
EYE IRRITATION |
7 |
0.0001 |
| 824 |
OSTEONECROSIS OF JAW |
3 |
0.0001 |
| 825 |
INJECTION SITE ERYTHEMA |
15 |
0.0001 |
| 826 |
DEHYDRATION |
16 |
0.0001 |
| 827 |
SKIN DISORDER |
4 |
0.0001 |
| 828 |
URINARY RETENTION |
4 |
0.0001 |
| 829 |
DYSPHONIA |
7 |
0.0001 |
| 830 |
CHILLS |
14 |
0.0001 |
| 831 |
CANDIDA INFECTION |
2 |
0.0001 |
| 832 |
DIABETES MELLITUS |
9 |
0.0001 |
| 833 |
INJECTION SITE SWELLING |
9 |
0.0001 |
| 834 |
ERECTILE DYSFUNCTION |
3 |
0.0001 |
| 835 |
SCAR |
2 |
0.0001 |
| 836 |
DRUG RESISTANCE |
3 |
0.0001 |
| 837 |
GASTRIC DISORDER |
4 |
0.0001 |
| 838 |
RASH GENERALISED |
3 |
0.0001 |
| 839 |
LOCAL SWELLING |
2 |
0.0001 |
| 840 |
COLD SWEAT |
2 |
0.0001 |
| 841 |
ISCHAEMIC STROKE |
2 |
0.0001 |
| 842 |
SKIN BURNING SENSATION |
8 |
0.0001 |
| 843 |
PAIN OF SKIN |
3 |
0.0001 |
| 844 |
PELVIC PAIN |
2 |
0.0001 |
| 845 |
AGITATION |
8 |
0.0001 |
| 846 |
SKIN DISCOLOURATION |
5 |
0.0001 |
| 847 |
BLOOD GLUCOSE ABNORMAL |
2 |
0.0001 |
| 848 |
RENAL DISORDER |
5 |
0.0001 |
| 849 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 850 |
COGNITIVE DISORDER |
5 |
0.0001 |
| 851 |
OXYGEN SATURATION DECREASED |
6 |
0.0001 |
| 852 |
TUBULOINTERSTITIAL NEPHRITIS |
2 |
0.0001 |
| 853 |
FRACTURE |
2 |
0.0001 |
| 854 |
BLOOD PRESSURE DECREASED |
7 |
0.0001 |
| 855 |
PROTEINURIA |
2 |
0.0001 |
| 856 |
NEUROPATHY PERIPHERAL |
10 |
0.0001 |
| 857 |
MULTIPLE SCLEROSIS |
5 |
0.0001 |
| 858 |
HERPES ZOSTER |
6 |
0.0001 |
| 859 |
LETHARGY |
6 |
0.0001 |
| 860 |
DRUG PRESCRIBING ERROR |
2 |
0.0001 |
| 861 |
AFFECT LABILITY |
1 |
0.0001 |
| 862 |
PANCREATIC CARCINOMA |
3 |
0.0001 |
| 863 |
NEEDLE ISSUE |
3 |
0.0001 |
| 864 |
HAEMORRHOIDS |
2 |
0.0001 |
| 865 |
TREMOR |
17 |
0.0001 |
| 866 |
ABNORMAL BEHAVIOUR |
4 |
0.0001 |
| 867 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 868 |
SUICIDAL IDEATION |
9 |
0.0001 |
| 869 |
BLINDNESS |
4 |
0.0001 |
| 870 |
INJECTION SITE WARMTH |
2 |
0.0001 |
| 871 |
TOOTH LOSS |
2 |
0.0001 |
| 872 |
SWOLLEN TONGUE |
3 |
0.0001 |
| 873 |
EATING DISORDER |
2 |
0.0001 |
| 874 |
PLATELET COUNT DECREASED |
10 |
0.0001 |
| 875 |
HIP FRACTURE |
3 |
0.0001 |
| 876 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 877 |
SWELLING FACE |
6 |
0.0001 |
| 878 |
DEVICE DISLOCATION |
4 |
0.0001 |
| 879 |
OSTEONECROSIS |
3 |
0.0001 |
| 880 |
MELAENA |
2 |
0.0001 |
| 881 |
EMOTIONAL DISTRESS |
11 |
0.0001 |
| 882 |
RENAL FAILURE |
12 |
0.0001 |
| 883 |
HYPOTENSION |
18 |
0.0001 |
| 884 |
SEPSIS |
10 |
0.0001 |
| 885 |
RASH PAPULAR |
2 |
0.0001 |
| 886 |
TRANSIENT ISCHAEMIC ATTACK |
3 |
0.0001 |
| 887 |
ANGER |
3 |
0.0001 |
| 888 |
HEART RATE IRREGULAR |
2 |
0.0001 |
| 889 |
MYALGIA |
15 |
0.0001 |
| 890 |
PRODUCT AVAILABILITY ISSUE |
2 |
0.0001 |
| 891 |
NEPHROLITHIASIS |
4 |
0.0001 |
| 892 |
SHOCK |
2 |
0.0001 |
| 893 |
MUSCLE TWITCHING |
2 |
0.0001 |
| 894 |
NEOPLASM PROGRESSION |
3 |
0.0001 |
| 895 |
HAEMORRHAGE |
9 |
0.0001 |
| 896 |
ARRHYTHMIA |
4 |
0.0001 |
| 897 |
CEREBRAL HAEMORRHAGE |
3 |
0.0001 |
| 898 |
HEPATIC CANCER |
2 |
0.0001 |
| 899 |
WHITE BLOOD CELL COUNT DECREASED |
9 |
0.0001 |
| 900 |
CRYING |
3 |
0.0001 |
| 901 |
PRESYNCOPE |
2 |
0.0001 |
| 902 |
ABASIA |
2 |
0.0001 |
| 903 |
INTESTINAL OBSTRUCTION |
3 |
0.0001 |
| 904 |
HAEMATEMESIS |
2 |
0.0001 |
| 905 |
HEPATITIS |
2 |
0.0001 |
| 906 |
SEIZURE |
9 |
0.0001 |
| 907 |
HAEMOGLOBIN DECREASED |
8 |
0.0001 |
| 908 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 909 |
SKIN ULCER |
2 |
0.0001 |
| 910 |
DEAFNESS |
2 |
0.0001 |
| 911 |
MUCOSAL INFLAMMATION |
2 |
0.0001 |
| 912 |
BEDRIDDEN |
1 |
0.0001 |
| 913 |
NEOPLASM MALIGNANT |
5 |
0.0001 |
| 914 |
NEUTROPHIL COUNT DECREASED |
3 |
0.0001 |
| 915 |
PNEUMONITIS |
2 |
0.0001 |
| 916 |
MOOD ALTERED |
2 |
0.0001 |
| 917 |
DRUG DOSE OMISSION |
12 |
0.0001 |
| 918 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 919 |
BURNING SENSATION |
5 |
0.0001 |
| 920 |
HYPERHIDROSIS |
9 |
0.0001 |
| 921 |
ANGINA PECTORIS |
2 |
0.0001 |
| 922 |
PRODUCT SUBSTITUTION ISSUE |
4 |
0.0001 |
| 923 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 924 |
PSYCHOTIC DISORDER |
2 |
0.0001 |
| 925 |
UNEVALUABLE EVENT |
5 |
0.0001 |
| 926 |
PLEURAL EFFUSION |
4 |
0.0001 |
| 927 |
ANKLE FRACTURE |
1 |
0.0001 |
| 928 |
CARDIAC DISORDER |
6 |
0.0001 |
| 929 |
NERVOUS SYSTEM DISORDER |
2 |
0.0001 |
| 930 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 931 |
INJECTION SITE HAEMORRHAGE |
5 |
0.0001 |
| 932 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 933 |
CARDIAC FAILURE CONGESTIVE |
5 |
0.0001 |
| 934 |
ATRIAL FIBRILLATION |
6 |
0.0001 |
| 935 |
INFLUENZA LIKE ILLNESS |
5 |
0.0001 |
| 936 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 937 |
RENAL IMPAIRMENT |
5 |
0.0001 |
| 938 |
CEREBROVASCULAR ACCIDENT |
10 |
0.0001 |
| 939 |
ACUTE KIDNEY INJURY |
9 |
0.0001 |
| 940 |
HAEMATURIA |
2 |
0.0001 |
| 941 |
MULTIPLE SCLEROSIS RELAPSE |
4 |
0.0001 |
| 942 |
ANAEMIA |
11 |
0.0001 |
| 943 |
AMENORRHOEA |
1 |
0.0001 |
| 944 |
HEART RATE DECREASED |
2 |
0.0001 |
| 945 |
DEVICE MALFUNCTION |
4 |
0.0001 |
| 946 |
DRUG INTERACTION |
9 |
0.0001 |
| 947 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 948 |
THERAPY INTERRUPTED |
4 |
0.0001 |
| 949 |
HYPERGLYCAEMIA |
2 |
0.0001 |
| 950 |
BREAST CANCER |
5 |
0.0001 |
| 951 |
HALLUCINATION |
4 |
0.0001 |
| 952 |
ACNE |
4 |
0.0001 |
| 953 |
CONVULSION |
3 |
0.0001 |
| 954 |
DEATH |
45 |
0.0001 |
| 955 |
MYOCARDIAL INFARCTION |
9 |
0.0001 |
| 956 |
DRUG DOSE OMISSION BY DEVICE |
4 |
0.0001 |
| 957 |
DISORIENTATION |
2 |
0.0001 |
| 958 |
DEVICE BREAKAGE |
2 |
0.0000 |
| 959 |
GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0000 |
| 960 |
RENAL FAILURE ACUTE |
2 |
0.0000 |
| 961 |
HYPOACUSIS |
2 |
0.0000 |
| 962 |
MENTAL DISORDER |
2 |
0.0000 |
| 963 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 964 |
PRODUCT STORAGE ERROR |
4 |
0.0000 |
| 965 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 966 |
NO ADVERSE EVENT |
8 |
0.0000 |
| 967 |
RENAL CANCER |
2 |
0.0000 |
| 968 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 969 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 970 |
AGGRESSION |
2 |
0.0000 |
| 971 |
MALIGNANT NEOPLASM PROGRESSION |
4 |
0.0000 |
| 972 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 973 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 974 |
PROSTATE CANCER |
3 |
0.0000 |
| 975 |
NEUTROPENIA |
5 |
0.0000 |
| 976 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 977 |
DRUG WITHDRAWAL SYNDROME |
3 |
0.0000 |
| 978 |
ASCITES |
1 |
0.0000 |
| 979 |
APHASIA |
1 |
0.0000 |
| 980 |
DEVICE DIFFICULT TO USE |
2 |
0.0000 |
| 981 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 982 |
BLOOD GLUCOSE INCREASED |
5 |
0.0000 |
| 983 |
CARDIAC FAILURE |
2 |
0.0000 |
| 984 |
DRUG DEPENDENCE |
4 |
0.0000 |
| 985 |
DEVICE ISSUE |
2 |
0.0000 |
| 986 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 987 |
SYNCOPE |
2 |
0.0000 |
| 988 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 989 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |